Shares of Masimo Corp. (NASDAQ:MASI) were up 2.7% during trading on Tuesday . The company traded as high as $57.47 and last traded at $57.25, with a volume of 231,472 shares trading hands. The stock had previously closed at $55.72.

A number of analysts have commented on MASI shares. Wedbush reiterated an “outperform” rating and issued a $63.00 price target (up previously from $60.00) on shares of Masimo Corp. in a research note on Thursday, August 4th. Zacks Investment Research upgraded shares of Masimo Corp. from a “hold” rating to a “buy” rating and set a $51.00 price target for the company in a research note on Friday, May 6th. Piper Jaffray Cos. reiterated an “overweight” rating and issued a $55.00 price target (up previously from $52.00) on shares of Masimo Corp. in a research note on Friday, August 5th. BTIG Research reiterated a “hold” rating on shares of Masimo Corp. in a research note on Friday, August 5th. Finally, Roth Capital increased their price target on shares of Masimo Corp. from $40.00 to $50.00 and gave the company a “buy” rating in a research note on Thursday, May 5th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $52.60.

The company has a market cap of $2.85 billion and a P/E ratio of 30.32. The firm’s 50-day moving average is $52.86 and its 200 day moving average is $45.18.

Masimo Corp. (NASDAQ:MASI) last released its quarterly earnings data on Wednesday, August 3rd. The company reported $0.57 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.16. The company earned $172.64 million during the quarter, compared to the consensus estimate of $166.02 million. The business’s revenue was up 10.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.36 EPS. On average, equities research analysts predict that Masimo Corp. will post $2.02 EPS for the current fiscal year.

In other Masimo Corp. news, Director Sanford Fitch sold 2,000 shares of the business’s stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $52.62, for a total transaction of $105,240.00. Following the completion of the sale, the director now owns 56,000 shares in the company, valued at approximately $2,946,720. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Joe E. Kiani sold 234,952 shares of the business’s stock in a transaction on Friday, June 3rd. The shares were sold at an average price of $50.09, for a total transaction of $11,768,745.68. Following the sale, the chief executive officer now owns 313,797 shares of the company’s stock, valued at approximately $15,718,091.73. The disclosure for this sale can be found here.

A number of hedge funds have made changes to their positions in the stock. Trexquant Investment LP acquired a new stake in shares of Masimo Corp. during the fourth quarter worth approximately $1,009,000. GSA Capital Partners LLP raised its stake in shares of Masimo Corp. by 160.1% in the fourth quarter. GSA Capital Partners LLP now owns 29,151 shares of the company’s stock worth $1,210,000 after buying an additional 17,944 shares during the period. New York State Common Retirement Fund raised its stake in shares of Masimo Corp. by 2.0% in the fourth quarter. New York State Common Retirement Fund now owns 65,782 shares of the company’s stock worth $2,731,000 after buying an additional 1,300 shares during the period. Cornerstone Capital Management Holdings LLC. raised its stake in shares of Masimo Corp. by 28.8% in the fourth quarter. Cornerstone Capital Management Holdings LLC. now owns 85,547 shares of the company’s stock worth $3,551,000 after buying an additional 19,147 shares during the period. Finally, State of Tennessee Treasury Department raised its stake in shares of Masimo Corp. by 41.6% in the fourth quarter. State of Tennessee Treasury Department now owns 155,800 shares of the company’s stock worth $6,467,000 after buying an additional 45,800 shares during the period.

Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.